Lantern Pharma Inc. (LTRN) Social Stream



Lantern Pharma Inc. (LTRN): $5.73

-0.20 (-3.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LTRN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 423

in industry

Featured Post From StockTwits About LTRN

$LTRN New Press Release:

Lantern Pharma Announces Abstract on Effectiveness of LP-184 in Pancreatic Cancers Accepted for Presentation at the AACR Virtual Special Conference: Pancreatic Cancer

Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Lantern Pharma's abstract titled 'LP-184, a novel alkylating agent, is highly effective in pancreatic cancers with DNA damage repair defects' has been accepted as a virtual poster at the upcoming AACR Virtual Special Conference on Pancreatic Cancer (...)

https://wchr.one/114345
WebChronicleToday, published August 16, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4038 seconds.